Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Finasteride reduces hair growth and is safe for women with excessive hair.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

The document is a detailed medical reference on skin and genetic disorders.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.